Gareth Betts

1.9k total citations
19 papers, 924 citations indexed

About

Gareth Betts is a scholar working on Immunology, Oncology and Infectious Diseases. According to data from OpenAlex, Gareth Betts has authored 19 papers receiving a total of 924 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 8 papers in Oncology and 4 papers in Infectious Diseases. Recurrent topics in Gareth Betts's work include Immune Cell Function and Interaction (11 papers), T-cell and B-cell Immunology (10 papers) and Immunotherapy and Immune Responses (8 papers). Gareth Betts is often cited by papers focused on Immune Cell Function and Interaction (11 papers), T-cell and B-cell Immunology (10 papers) and Immunotherapy and Immune Responses (8 papers). Gareth Betts collaborates with scholars based in United Kingdom and Israel. Gareth Betts's co-authors include Andrew Godkin, Awen Gallimore, B I Rees, Tariq El‐Shanawany, Sarah L. Clarke, Emma Jones, Helen McShane, Hazel Poyntz, Elena Stylianou and Geraint T. Williams and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Gareth Betts

19 papers receiving 910 citations

Peers

Countries citing papers authored by Gareth Betts

Since Specialization

Citations

This map shows the geographic impact of Gareth Betts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gareth Betts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gareth Betts more than expected).

Fields of papers citing papers by Gareth Betts

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gareth Betts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gareth Betts. The network helps show where Gareth Betts may publish in the future.

Co-authorship network of co-authors of Gareth Betts

This figure shows the co-authorship network connecting the top 25 collaborators of Gareth Betts. A scholar is included among the top collaborators of Gareth Betts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gareth Betts. Gareth Betts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	373 Enhancement of TCR-engineered T-cells targeting MAGE-A4 antigen by co-expression of CD8α and inhibition of AKT signaling during ex vivo T-cell expansion 2021 ·Regular and Young Investigator Award Abstracts ·Emily M. Schmidt, Katerina Mardilovich, Natalie Bath, Gareth Betts, (unknown), (unknown), Ian J. Donaldson, Cheryl McAlpine, (unknown), Jean‐Marc Navenot, Joseph P. Sanderson, (unknown), Chris Evans, Karen Miller, Quan Lin, Mark E. Dudley, Alex J. Tipping	3
2	95 Inhibition of AKT signaling during expansion of TCR-engineered T-cells from patient leukocyte material generates SPEAR T-cells with enhanced functional potential in vitro 2020 ·Regular and Young Investigator Award Abstracts ·Katerina Mardilovich, Lili Wang, (unknown), Gareth Betts, Natalie Bath, (unknown), Vanessa D. de Mello, Seint T. Lwin, Joseph P. Sanderson, Jonathan D. Silk, Alex J. Tipping, Andrew B. Gerry, (unknown), Karen Miller, Mark E. Dudley, Emily M. Schmidt	1
3	Transiently Activated Human Regulatory T Cells Upregulate BCL-XL Expression and Acquire a Functional Advantage in vivo 2019 ·Frontiers in Immunology ·Fadi Issa, Kate Milward, Ryoichi Goto, Gareth Betts, Kathryn J. Wood, Joanna Hester	11
4	CD45RA Distinguishes CD4+CD25+CD127−/low TSDR Demethylated Regulatory T Cell Subpopulations With Differential Stability and Susceptibility to Tacrolimus-Mediated Inhibition of Suppression 2016 ·Transplantation ·Rebeca Arroyo Hornero, Gareth Betts, Birgit Sawitzki, Katrin Vogt, Paul Harden, Kathryn J. Wood	56
5	Improvement of BCG protective efficacy with a novel chimpanzee adenovirus and a modified vaccinia Ankara virus both expressing Ag85A 2015 ·Vaccine ·Elena Stylianou, Kristin Griffiths, Hazel Poyntz, Rachel Harrington-Kandt, Matthew D. J. Dicks, Lisa Stockdale, Gareth Betts, Helen McShane	87
6	Assessing the Prognostic Value of Preoperative Carcinoembryonic Antigen-Specific T-Cell Responses in Colorectal Cancer 2015 ·JNCI Journal of the National Cancer Institute ·Martin Scurr, (unknown), (unknown), Gareth Betts, B I Rees, Robert K. Hills, Awen Gallimore, Andrew Godkin	15
7	Evaluation of the Safety and Immunogenicity of a Candidate Tuberculosis Vaccine, MVA85A, Delivered by Aerosol to the Lungs of Macaques 2013 ·Clinical and Vaccine Immunology ·Andrew White, Laura Sibley, Mike Dennis, Karen E. Gooch, Gareth Betts, Nick J. Edwards, Arturo Reyes‐Sandoval, Miles W. Carroll, Ann Williams, Philip D. Marsh, Helen McShane, S. Sharpe	64
8	Nasopharyngeal Carcinoma – A Retrospective Review of Demographics, Treatment and Patient Outcome in a Single Centre 2013 ·Clinical Oncology ·Rovel Colaco, Gareth Betts, Adam J. Donne, R. Swindell, B. Yap, Andrew Sykes, N.J. Slevin, Jarrod J. Homer, (unknown)	52
9	Cholera Toxin Enhances Vaccine-Induced Protection against Mycobacterium Tuberculosis Challenge in Mice 2013 ·PLoS ONE ·Kristin Griffiths, Elena Stylianou, Hazel Poyntz, Gareth Betts, Helen A. Fletcher, Helen McShane	18
10	Optimising Immunogenicity with Viral Vectors: Mixing MVA and HAdV-5 Expressing the Mycobacterial Antigen Ag85A in a Single Injection 2012 ·PLoS ONE ·Gareth Betts, Hazel Poyntz, Elena Stylianou, Arturo Reyes‐Sandoval, Matthew G. Cottingham, Adrian V. S. Hill, Helen McShane	23
11	Suppression of tumour-specific CD4 ⁺ T cells by regulatory T cells is associated with progression of human colorectal cancer 2011 ·Gut ·Gareth Betts, Emma Jones, (unknown), Tariq El‐Shanawany, Martin Scurr, (unknown), (unknown), (unknown), B I Rees, Geraint T. Williams, Awen Gallimore, Andrew Godkin	136
12	Analysis of the T-Cell Receptor Repertoires of Tumor-Infiltrating Conventional and Regulatory T Cells Reveals No Evidence for Conversion in Carcinogen-Induced Tumors 2010 ·Cancer Research ·James P. Hindley, Cristina Ferreira, Emma Jones, Sarah N. Lauder, Kristin Ladell, Katherine K. Wynn, Gareth Betts, Yogesh Singh, David A. Price, Andrew Godkin, Julian Dyson, Awen Gallimore	97
13	CD59 Blockade Enhances Antigen-Specific CD4+ T Cell Responses in Humans: A New Target for Cancer Immunotherapy? 2009 ·The Journal of Immunology ·Baalasubramanian Sivasankar, M. Paula Longhi, Kathleen Gallagher, Gareth Betts, B. Paul Morgan, Andrew Godkin, Awen Gallimore	44
14	Expansion of hepatitis C–specific CD4+CD25+ regulatory T cells after viral clearance: A mechanism to limit collateral damage? 2008 ·Journal of Allergy and Clinical Immunology ·Andrew Godkin, Wan‐Fai Ng, Kathleen Gallagher, Gareth Betts, Howard C. Thomas, Robert I. Lechler	16
15	The impact of regulatory T cells on carcinogen-induced sarcogenesis 2007 ·British Journal of Cancer ·Gareth Betts, Jason P. Twohig, Maries van den Broek, Sophie Sierro, Andrew Godkin, Awen Gallimore	56
16	Regulatory T cells inhibit Fas ligand‐induced innate and adaptive tumour immunity 2007 ·European Journal of Immunology ·Anna Katharina Simon, Emma Jones, Hannah Richards, (unknown), Gareth Betts, Andrew Godkin, Gavin Screaton, Awen Gallimore	23
17	Reply: Forkhead box P3-positive regulatory T cells in immune surveillance and cancer 2007 ·British Journal of Cancer ·Gareth Betts, Andrew Godkin, Awen Gallimore	1
18	Regulating the immune response to tumours 2006 ·Advanced Drug Delivery Reviews ·Gareth Betts, Sarah L. Clarke, Hannah Richards, Andrew Godkin, Awen Gallimore	45
19	CD4+CD25+FOXP3+ Regulatory T Cells Suppress Anti-Tumor Immune Responses in Patients with Colorectal Cancer 2006 ·PLoS ONE ·Sarah L. Clarke, Gareth Betts, Andrea Plant, (unknown), Tariq El‐Shanawany, Richard Harrop, Jared Torkington, B I Rees, Geraint T. Williams, Awen Gallimore, Andrew Godkin	176

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact